Sanofi
SNY
SNY
474 hedge funds and large institutions have $11.3B invested in Sanofi in 2017 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 127 increasing their positions, 187 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% less capital invested
Capital invested by funds: $11.4B → $11.3B (-$33.8M)
0.67% less ownership
Funds ownership: 19.33% → 18.66% (-0.67%)
32% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 187
Holders
474
Holding in Top 10
10
Calls
$88.5M
Puts
$10.9M
Top Buyers
1 | +$70.3M | |
2 | +$57.5M | |
3 | +$49M | |
4 |
BlackRock
New York
|
+$34.5M |
5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$28.4M |
Top Sellers
1 | -$254M | |
2 | -$217M | |
3 | -$197M | |
4 |
SAM
Senzar Asset Management
New York
|
-$69.6M |
5 |
SAC
Smith Affiliated Capital
New York
|
-$56.6M |